Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Molecular Biology Regulatory guidance recommends the inclusion of pharmacogenomic investigations during the drug or biological product development process, therefore you need a partner that can offer you the most advanced and reliable assays as well as the flexibility to tailor them to your specifications. Leveraging the latest technologies such as real-time quantitative PCR (qPCR) and real-time reverse transcriptase qPCR (RT-qPCR), Charles River performs a comprehensive array of genomics-based assays to support all phases of drug development, from discovery and preclinical studies through clinical trials, in either singleplex or multiplex formats. Our Facilities Our molecular biology facilities have custom-designed, dedicated laboratories with separate sample processing (e.g., nucleic acid extraction), reagent preparation and amplification/product detection areas to minimize the possibility of cross-contamination. We can isolate and purify DNA and RNA from a variety of tissues, body fluids, cells in culture or any other biological sample. Our extraction procedures are optimized to provide the highest quality real-time qPCR results; both quality and yield of extracted nucleic acid samples are assessed prior to being used in the qPCR assay. Technical Capabilities Charles River has invested in leading-edge, real-time qPCR platforms capable of supporting multiple fluorescent chemistries, such as TaqMan® and SYBR® Green, to facilitate the development of the most sensitive and robust qPCR assays for your products. Our real-time qPCR platforms are also capable of performing allelic discrimination assays using next-generation TaqMan® probe chemistry. Regulatory Expertise and Compliance Charles River has vast experience in the development of assays for gene expression studies or target gene detection. Our expertise includes assay development, sample processing, and data analysis and interpretation. Molecular assays are validated to Food and Drug Administration (FDA), Organisation for Economic Co-operation and Development (OECD), Ministry of Health, Labour and Welfare (MHLW) and International Conference on Harmonisation (ICH) guidelines, and are compliant with GLP or GMP, as required. Services • Allelic discrimination assays (SNP genotyping) • Assay feasibility, development and validation • Biological sample analysis • Biomarker assessment • Biosafety testing -- Adventitious agents testing by qPCR/ RT-qPCR -- PCR-based reverse transcriptase testing -- PCR-based mycoplasma testing • Cell line authentication -- Barcode of Life sequence analysis -- Human and Vero short tandem repeat (STR) analysis • Cell line characterization (mammalian, fungal, bacterial) -- Restriction endonuclease analysis -- Gene copy number -- Recombinant gene sequencing -- Transcript sequencing • Cytokine mRNA profiling in immune response • Gene expression analysis • Genomic and plasmid DNA isolation • Microbial contaminant identification by sequence analysis • Nucleic acid therapeutic assessments -- Biodistribution studies -- Pharmacokinetics • Residual DNA detection by qPCR or hybridization analysis • RNA isolation and integrity assessment [email protected] www.criver.com © 2013, Charles River Laboratories International, Inc.